HydRegen
Enzyme biocatalysts replacing precious-metal catalysts in chemical hydrogenation
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
HydRegen is a University of Oxford spinout commercialising enzyme-based biocatalyst technology for hydrogenation reactions in pharmaceutical, specialty and bulk chemical manufacturing. Its slot-in products are designed to replace heavy-metal catalysts and fit existing batch or continuous-flow infrastructure. In October 2026 it announced an $8M (£6M) Series A first close led by Genoa Ventures, with Clean Growth Fund and First Imagine! Ventures participating.
- Website
- hydregenoxford.com
- Stage
- series-a
- Location
- Oxford, United Kingdom
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- HydRegen Bio2Amine — Heterogeneous biocatalyst for nitro-to-amine hydrogenation · Other · Enterprise